US Senate confirms Trump’s picks to lead FDA, NIH

Published 03/26/2025, 11:31 AM
Updated 03/26/2025, 05:36 PM
© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

(Reuters) -The U.S. Senate on Tuesday confirmed President Donald Trump’s nominees Martin Makary and Jay Bhattacharya as heads of the Food and Drug Administration and the National Institutes of Health, respectively.

The Republican-controlled Senate voted 56-44 to confirm Martin Makary as the commissioner of the FDA, which is currently embroiled in a controversy over the mass firing of federal employees.

The Senate voted 53-47 to confirm Jay Bhattacharya as director of the NIH, the nation’s premier medical research agency, overseeing a nearly $50 billion budget and funding for thousands of scientific projects.

Bhattacharya is set to face immediate challenges, including legal battles over Trump’s proposed cuts to federal research funding. A U.S. judge blocked the cuts earlier this month.

In the new roles, Makary and Bhattacharya will report to Health Secretary Robert F. Kennedy Jr who oversees the agencies.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.